Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the Literature (2024), Chaudhary | AcademicGPT, tlooto

A retrospective analysis of INOVA Schar Cancer patients registered in the authors' Molecular Tumor Board database with non-V600 BRAF mutations who were recipients of targeted therapy and assessed thei (2024), DRUGS IN R&D, Chaudhary H.A. | AcademicGPT, tlooto for Academic and Research